Brind.

Incepta Pharmaceuticals and Delcath Systems, Inc. are involved in a new industry ranking.

1 report, 1 independent Updated Jul 17

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Incepta Pharmaceuticals Delcath Systems, Inc.

Keep exploring

The entities involved

Incepta Pharmaceuticals
incepta
- Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Sun 03:24
- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.Sat 20:39
Delcath Systems, Inc.
Nothing else this week.

Related events

Both Delcath Systems and Curaleaf are facing market scrutiny as healthcare companies.Sep 22

Coverage

Newest first; wire copies grouped

Jul 17ZacksIs the Options Market Predicting a Spike in Delcath Systems Stock? Investors in Delcath Systems, Inc. DCTH need to pay close attention to the stock based on moves in the options market lately. That i